Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Dufour, Julie ^a,b,c,d   Pommier, Aurélien ^a,b,c,d   Alves, Georges ^a,b,c,d   de Boussac, Hugues ^a,b,c,d   Lours Calet, Corinne ^a,b,c,d   Volle, David H ^a,b,c,d   Lobaccaro, Jean Marc A ^a,b,c,d   Baron, Silvère ^a,b,c,d  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

^c Faculté de Médecine   (France)

^d CRNH AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CELL PROTEIN; FAS ANTIGEN; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ACC; PROTEIN IDOL; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; MOLECULAR MODEL; MOUSE; NONHUMAN; PROSTATE EPITHELIUM; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; GENE ORDER; GENE TARGETING; GENOTYPE; HOMEOSTASIS; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; ORPHAN NUCLEAR RECEPTORS; PROSTATE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 84874922871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058876     Document Type: Article

References (24)

1. Faulds MH, Zhao C, Dahlman-Wright K, (2010) Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol 10: 692-697 doi:10.1016/j.coph.2010.07.003.
2. Calkin AC, Tontonoz P, (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13: 213-224 doi:10.1038/nrm3312.
3. Kim HJ, Andersson LC, Bouton D, Warner M, Gustafsson JA, (2009) Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc Natl Acad Sci U S A 106: 558-563.
4. Viennois E, Esposito T, Dufour J, Pommier A, Fabre S, et al. (2012) Lxrα regulates the androgen response in prostate epithelium. Endocrinology 153: 3211-3223 doi:10.1210/en.2011-1996.
5. Chuu CP, Kokontis JM, Hiipakka RA, Liao S, (2007) Modulation of liver X receptor signaling as novel therapy for prostate cancer. J Biomed Sci. 14: 543-53.
6. Viennois E, Pommier AJ, Mouzat K, Oumeddour A, El Hajjaji FZ, et al. (2011) Targeting liver X receptors in human health: deadlock or promising trail? Expert Opin Ther Targets 15: 219-232 doi:10.1517/14728222.2011.547853.
7. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S, (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64: 7686-7689.
8. Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, et al. (2006) Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 66: 6482-6486.
9. Pommier AJ, Alves G, Viennois E, Bernard S, Communal Y, et al. (2010) Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 29: 2712-2723.
10. Fukuchi J, Hiipakka RA, Kokontis JM, Hsu S, Ko AL, et al. (2004) Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 64: 7682-7685.
11. Dufour J, Viennois E, De Boussac H, Baron S, Lobaccaro J-M, (2012) Oxysterol receptors, AKT and prostate cancer. Current opinion in pharmacology. 12(6): 724-8 doi:10.1016/j.coph.2012.06.012.
12. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, et al. (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64: 2270-2305.
13. Berquin IM, Min Y, Wu R, Wu H, Chen YQ, (2005) Expression signature of the mouse prostate. J Biol Chem 280: 36442-36451.
14. Manin M, Veyssiere G, Cheyvialle D, Chevalier M, Lecher P, et al. (1992) In vitro androgenic induction of a major protein in epithelial cell subcultures from mouse vas deferens. Endocrinology 131: 2378-2386.
15. Cummins CL, Volle DH, Zhang Y, McDonald JG, Sion B, et al. (2006) Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 116: 1902-1912.
16. Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro J-M, et al. (2012) Selective liver X receptor modulators (SLiMs): what use in human health? Mol Cell Endocrinol 351: 129-141 doi:10.1016/j.mce.2011.08.036.
17. Ding Z, Wu C-J, Chu GC, Xiao Y, Ho D, et al. (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470: 269-273 doi:10.1038/nature09677.
18. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529.
19. Mitro N, Vargas L, Romeo R, Koder A, Saez E, (2007) T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 581: 1721-1726.
20. Esquenet M, Swinnen JV, Heyns W, Verhoeven G, (1996) Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate 28: 182-194.
21. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, et al. (2001) Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 47: 102-110.
22. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, et al. (2003) Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 1: 707-715.
23. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, et al. (2007) Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 67: 8180-8187.
24. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93: 693-704.